George C. Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
George C. Wang has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Jeremy D. Walston
Johns Hopkins University School of Medicine
5 shared publications- Florian Kern
Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, United Kingdom
3 shared publications Linda P. Fried
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York
3 shared publications- Andrea Britta Maier
NUS Academy for Healthy Longevity, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore
2 shared publications - Ann B. Hill
Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America
2 shared publications - Arne N. Akbar
Department of Aging, Rheumatology and Regenerative Medicine, Division of Medicine, University College London, London, UK
2 shared publications
Latest Publications
- 29 May 2019
- Published by Springer Nature
- p. 2391-2416
CMV Infection and Frailty: Immunologic Consequences and Disease Pathogenesis
- 29 May 2019
- Published by Springer Nature
- p. 2391-2416
CMV Infection and Frailty: Immunologic Consequences and Disease Pathogenesis
- Open Access
- 8 November 2018
- Published by Springer Nature in Immunity & Ageing
- Vol. 15 (1) , 1-10
A comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD study
Patients with end-stage renal disease (ESRD) exhibit a premature aging phenotype of the immune system. Nevertheless, the etiology and impact of these changes in ESRD patients remain unknown. Compared to healthy individuals, ESRD patients exhibit accelerated immunosenescence in both T cell and monocyte compartments, characterized by a dramatic reduction in naïve CD4+ and CD8+ T cell numbers but increase in CD8+ TEMRA cell and proinflammatory monocyte numbers. Notably, within ESRD patients, aging-related immune changes positively correlated not only with increasing age but also with longer dialysis vintage. In multivariable-adjusted logistic regression models, the combination of high terminally differentiated CD8+ T cell level and high intermediate monocyte level, as a composite predictive immunophenotype, was independently associated with prevalent coronary artery disease as well as cardiovascular disease, after adjustment for age, sex, systemic inflammation and presence of diabetes. Levels of terminally differentiated CD8+ T cells also positively correlated with the level of uremic toxin p-cresyl sulfate. Aging-associated adaptive and innate immune changes are aggravated in ESRD and are associated with cardiovascular diseases. For the first time, our study demonstrates the potential link between immunosenescence in ESRD and duration of exposure to the uremic milieu.
- 8 November 2018
- Published by Springer Nature in Immunity & Ageing
- Vol. 15 (1) , 1-10
Open AccessA comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD study
Patients with end-stage renal disease (ESRD) exhibit a premature aging phenotype of the immune system. Nevertheless, the etiology and impact of these changes in ESRD patients remain unknown. Compared to healthy individuals, ESRD patients exhibit accelerated immunosenescence in both T cell and monocyte compartments, characterized by a dramatic reduction in naïve CD4+ and CD8+ T cell numbers but increase in CD8+ TEMRA cell and proinflammatory monocyte numbers. Notably, within ESRD patients, aging-related immune changes positively correlated not only with increasing age but also with longer dialysis vintage. In multivariable-adjusted logistic regression models, the combination of high terminally differentiated CD8+ T cell level and high intermediate monocyte level, as a composite predictive immunophenotype, was independently associated with prevalent coronary artery disease as well as cardiovascular disease, after adjustment for age, sex, systemic inflammation and presence of diabetes. Levels of terminally differentiated CD8+ T cells also positively correlated with the level of uremic toxin p-cresyl sulfate. Aging-associated adaptive and innate immune changes are aggravated in ESRD and are associated with cardiovascular diseases. For the first time, our study demonstrates the potential link between immunosenescence in ESRD and duration of exposure to the uremic milieu.
- 3 October 2017
- Published by Springer Nature
- p. 1-26
CMV Infection and Frailty: Immunologic Consequences and Disease Pathogenesis
- 3 October 2017
- Published by Springer Nature
- p. 1-26
CMV Infection and Frailty: Immunologic Consequences and Disease Pathogenesis
- 30 April 2016
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 64 (5) , 998-1005
Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies
Objectives: To examine the relationship between herpesvirus infections and mortality and incident frailty risks in community‐dwelling older women. Design: Nested prospective cohort study. Setting: Women's Health and Aging Studies I and II. Participants: Community‐dwelling older women aged 70 to 79 (n = 633). Measurements: Baseline serum antibody (immunoglobulin G) levels against four herpesviruses (herpes simplex virus types 1 (HSV‐1) and 2 (HSV‐2), varicella‐zoster virus (VZV), 7 Epstein‐Barr virus (EBV)), 3‐year incident frailty rates, and 5‐year mortality. Results: Women seropositive for HSV‐1 and HSV‐2, but not VZV and EBV, had higher risk of 3‐year incident frailty (HSV‐1: hazard ratio (HR) = 1.90, 95% confidence interval (CI) = 0.96–3.74; HSV‐2: HR = 2.10, 95% CI = 1.05–4.37) and 5‐year mortality (HR = 1.73, 95% CI = 0.93–3.20; HR = 1.80, 95% CI = 0.94–3.44, respectively) than seronegative women. Incremental increases in serum HSV‐1 and HSV‐2 antibody levels were associated with incrementally higher risks of incident frailty and mortality. After adjustment for potential confounders, only higher serum HSV‐2 antibody level was independently predictive of higher risk of mortality in older women (for each unit increase in antibody index, HR = 1.47, 95% CI = 1.05–2.07). Conclusion: HSV‐1 and HSV‐2 antibody levels are not independently associated with risk of incident frailty in older women. Only HSV‐2 antibody level is independently predictive of 5‐year mortality risk, with each incremental increase in the antibody level adding further risk.
- 30 April 2016
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 64 (5) , 998-1005
Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies
Objectives: To examine the relationship between herpesvirus infections and mortality and incident frailty risks in community‐dwelling older women. Design: Nested prospective cohort study. Setting: Women's Health and Aging Studies I and II. Participants: Community‐dwelling older women aged 70 to 79 (n = 633). Measurements: Baseline serum antibody (immunoglobulin G) levels against four herpesviruses (herpes simplex virus types 1 (HSV‐1) and 2 (HSV‐2), varicella‐zoster virus (VZV), 7 Epstein‐Barr virus (EBV)), 3‐year incident frailty rates, and 5‐year mortality. Results: Women seropositive for HSV‐1 and HSV‐2, but not VZV and EBV, had higher risk of 3‐year incident frailty (HSV‐1: hazard ratio (HR) = 1.90, 95% confidence interval (CI) = 0.96–3.74; HSV‐2: HR = 2.10, 95% CI = 1.05–4.37) and 5‐year mortality (HR = 1.73, 95% CI = 0.93–3.20; HR = 1.80, 95% CI = 0.94–3.44, respectively) than seronegative women. Incremental increases in serum HSV‐1 and HSV‐2 antibody levels were associated with incrementally higher risks of incident frailty and mortality. After adjustment for potential confounders, only higher serum HSV‐2 antibody level was independently predictive of higher risk of mortality in older women (for each unit increase in antibody index, HR = 1.47, 95% CI = 1.05–2.07). Conclusion: HSV‐1 and HSV‐2 antibody levels are not independently associated with risk of incident frailty in older women. Only HSV‐2 antibody level is independently predictive of 5‐year mortality risk, with each incremental increase in the antibody level adding further risk.
- Open Access
- 18 January 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 19227
Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size
Cytomegalovirus (CMV) infection is one of the most common persistent viral infections in humans worldwide and is epidemiologically associated with many adverse health consequences during aging. Previous studies yielded conflicting results regarding whether large, CMV-specific T-cell expansions maintain their function during human aging. In the current study, we examined the in vitro CMV-pp65-reactive T-cell response by comprehensively studying five effector functions (i.e., interleukin-2, tumor necrosis factor-α, interferon-γ, perforin and CD107a expression) in 76 seropositive individuals aged 70 years or older. Two data-driven, polyfunctionality panels (IL-2-associated and cytotoxicity-associated) derived from effector function co-expression patterns were used to analyze the results. We found that, CMV-pp65-reactive CD8 + and CD4 + T cells contained similar polyfunctional subsets and the level of polyfunctionality was related to the size of antigen-specific response. In both CD8 + and CD4 + cells, polyfunctional cells with high cytotoxic potential accounted for a larger proportion of the total response as the total response size increased. Notably, a higher serum CMV-IgG level was positively associated with a larger T-cell response size and a higher level of cytotoxic polyfunctionality. These findings indicate that CMV-pp65-specific CD4 + and CD8 + T cell undergo simultaneous cytotoxic polyfunctionality maturation during aging.
- 18 January 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 19227
Open AccessCytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size
Cytomegalovirus (CMV) infection is one of the most common persistent viral infections in humans worldwide and is epidemiologically associated with many adverse health consequences during aging. Previous studies yielded conflicting results regarding whether large, CMV-specific T-cell expansions maintain their function during human aging. In the current study, we examined the in vitro CMV-pp65-reactive T-cell response by comprehensively studying five effector functions (i.e., interleukin-2, tumor necrosis factor-α, interferon-γ, perforin and CD107a expression) in 76 seropositive individuals aged 70 years or older. Two data-driven, polyfunctionality panels (IL-2-associated and cytotoxicity-associated) derived from effector function co-expression patterns were used to analyze the results. We found that, CMV-pp65-reactive CD8 + and CD4 + T cells contained similar polyfunctional subsets and the level of polyfunctionality was related to the size of antigen-specific response. In both CD8 + and CD4 + cells, polyfunctional cells with high cytotoxic potential accounted for a larger proportion of the total response as the total response size increased. Notably, a higher serum CMV-IgG level was positively associated with a larger T-cell response size and a higher level of cytotoxic polyfunctionality. These findings indicate that CMV-pp65-specific CD4 + and CD8 + T cell undergo simultaneous cytotoxic polyfunctionality maturation during aging.
- Open Access
- 31 October 2012
- Published by Springer Nature in Immunity & Ageing
- Vol. 9 (1) , 23
CMV and Immunosenescence: from basics to clinics
Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates “immunosenescence”. This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop.
- 31 October 2012
- Published by Springer Nature in Immunity & Ageing
- Vol. 9 (1) , 23
Open AccessCMV and Immunosenescence: from basics to clinics
Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates “immunosenescence”. This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop.
- 4 April 2012
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 4 (128) , 128ra42
T Cell Receptor αβ Diversity Inversely Correlates with Pathogen-Specific Antibody Levels in Human Cytomegalovirus Infection
CD8 + T cell diversity may be more important than T cell abundance in limiting the negative consequences of cytomegalovirus persistence.
- 4 April 2012
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 4 (128) , 128ra42
T Cell Receptor αβ Diversity Inversely Correlates with Pathogen-Specific Antibody Levels in Human Cytomegalovirus Infection
CD8 + T cell diversity may be more important than T cell abundance in limiting the negative consequences of cytomegalovirus persistence.
- Open Access
- 28 October 2011
- Published by Springer Nature in Immunity & Ageing
- Vol. 8 (1) , 1-8
Report from the second cytomegalovirus and immunosenescence workshop
The Second International Workshop on CMV & Immunosenescence was held in Cambridge, UK, 2-4th December, 2010. The presentations covered four separate sessions: cytomegalovirus and T cell phenotypes; T cell memory frequency, inflation and immunosenescence; cytomegalovirus in aging, mortality and disease states; and the immunobiology of cytomegalovirus-specific T cells and effects of the virus on vaccination. This commentary summarizes the major findings of these presentations and references subsequently published work from the presenter laboratory where appropriate and draws together major themes that were subsequently discussed along with new areas of interest that were highlighted by this discussion.
- 28 October 2011
- Published by Springer Nature in Immunity & Ageing
- Vol. 8 (1) , 1-8
Open AccessReport from the second cytomegalovirus and immunosenescence workshop
The Second International Workshop on CMV & Immunosenescence was held in Cambridge, UK, 2-4th December, 2010. The presentations covered four separate sessions: cytomegalovirus and T cell phenotypes; T cell memory frequency, inflation and immunosenescence; cytomegalovirus in aging, mortality and disease states; and the immunobiology of cytomegalovirus-specific T cells and effects of the virus on vaccination. This commentary summarizes the major findings of these presentations and references subsequently published work from the presenter laboratory where appropriate and draws together major themes that were subsequently discussed along with new areas of interest that were highlighted by this discussion.
- Open Access
- 16 April 2010
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 171 (10) , 1144-1152
Cytomegalovirus Infection and the Risk of Mortality and Frailty in Older Women: A Prospective Observational Cohort Study
Cytomegalovirus (CMV), a prevalent pathogen, causes severe disease in immunocompromised humans. However, present understanding is limited regarding the long-term clinical effect of persistent CMV infection in immunocompetent adults. The authors conducted a prospective observational cohort study (1992–2002) of 635 community-dwelling women in Baltimore, Maryland, aged 70–79 years in the Women's Health and Aging Studies to examine the effect of CMV infection on the risk of frailty, a common geriatric syndrome, and mortality in older women. The effect of baseline serum CMV antibody (immunoglobulin G) concentration on the risk of 3-year incident frailty, defined by using a 5-component measure, and 5-year mortality was examined with Cox proportional hazards models. Compared with those who were CMV seronegative, women in the highest quartile of CMV antibody concentration had a greater incidence of frailty (hazard ratio = 3.46, 95% confidence interval: 1.45, 8.27) and mortality (hazard ratio = 3.81, 95% confidence interval: 1.64, 8.83). After adjustment for potential confounders, CMV antibody concentration in the highest quartile independently increased the risk of 5-year mortality (hazard ratio = 2.79, 95% confidence interval: 1.22, 6.40). Better understanding of the long-term clinical consequences of CMV infection in immunocompetent humans is needed to guide public health efforts for this widely prevalent infection.
- 16 April 2010
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 171 (10) , 1144-1152
Open AccessCytomegalovirus Infection and the Risk of Mortality and Frailty in Older Women: A Prospective Observational Cohort Study
Cytomegalovirus (CMV), a prevalent pathogen, causes severe disease in immunocompromised humans. However, present understanding is limited regarding the long-term clinical effect of persistent CMV infection in immunocompetent adults. The authors conducted a prospective observational cohort study (1992–2002) of 635 community-dwelling women in Baltimore, Maryland, aged 70–79 years in the Women's Health and Aging Studies to examine the effect of CMV infection on the risk of frailty, a common geriatric syndrome, and mortality in older women. The effect of baseline serum CMV antibody (immunoglobulin G) concentration on the risk of 3-year incident frailty, defined by using a 5-component measure, and 5-year mortality was examined with Cox proportional hazards models. Compared with those who were CMV seronegative, women in the highest quartile of CMV antibody concentration had a greater incidence of frailty (hazard ratio = 3.46, 95% confidence interval: 1.45, 8.27) and mortality (hazard ratio = 3.81, 95% confidence interval: 1.64, 8.83). After adjustment for potential confounders, CMV antibody concentration in the highest quartile independently increased the risk of 5-year mortality (hazard ratio = 2.79, 95% confidence interval: 1.22, 6.40). Better understanding of the long-term clinical consequences of CMV infection in immunocompetent humans is needed to guide public health efforts for this widely prevalent infection.
- Open Access
- 1 March 2010
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (3) , 1161-1168
Thyroid Autoantibodies Are Associated with a Reduced Prevalence of Frailty in Community-Dwelling Older Women
Context: The contribution of autoimmunity to the multisystem dysregulation that characterizes the frailty syndrome in older adults is unknown. Objective: The aim of the study was to investigate the relationship between thyroid antibodies and frailty in older women. Design, Setting, and Participants: We conducted a cross-sectional study nested within the Women’s Health and Aging Studies I and II. Thyroglobulin antibodies (TgAbs), thyroid peroxidase antibodies (TPOAbs), and antinuclear antibodies were measured in the baseline sera of 641 community-dwelling older women. Main Outcome Measure: Frailty was defined using a validated five-component measure. Results: The prevalence of prefrailty and frailty was lower in TgAb-positive than negative older women (37.1 vs. 47.8% and 6.7 vs.11.9%, respectively; P = 0.01 and 0.03). The prevalence of prefrailty, but not frailty, was lower in TPOAb-positive than negative women (38.9 vs. 48.0% and 10.1 vs. 11.3%; P = 0.04 and 0.34). After adjustment for covariates including serum thyroid stimulation hormone concentration and thyroid medication usage in multinomial regression models, TgAb-positive older women had lower odds of prefrailty and frailty compared with TgAb-negative women (odds ratio 0.57 and 0.30; 95% confidence interval 0.34–0.98 and 0.10–0.85, respectively). Similarly, TPOAb-positive older women had lower odds of frailty compared with TPOAb-negative women (odds ratio 0.44; 95% confidence interval 0.20–0.96). These trends were not observed with antinuclear antibodies. Conclusion: Independent of thyroid function status, community-dwelling older women who are seropositive for TgAbs and TPOAbs are less likely to be frail than seronegative women.
- 1 March 2010
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (3) , 1161-1168
Open AccessThyroid Autoantibodies Are Associated with a Reduced Prevalence of Frailty in Community-Dwelling Older Women
Context: The contribution of autoimmunity to the multisystem dysregulation that characterizes the frailty syndrome in older adults is unknown. Objective: The aim of the study was to investigate the relationship between thyroid antibodies and frailty in older women. Design, Setting, and Participants: We conducted a cross-sectional study nested within the Women’s Health and Aging Studies I and II. Thyroglobulin antibodies (TgAbs), thyroid peroxidase antibodies (TPOAbs), and antinuclear antibodies were measured in the baseline sera of 641 community-dwelling older women. Main Outcome Measure: Frailty was defined using a validated five-component measure. Results: The prevalence of prefrailty and frailty was lower in TgAb-positive than negative older women (37.1 vs. 47.8% and 6.7 vs.11.9%, respectively; P = 0.01 and 0.03). The prevalence of prefrailty, but not frailty, was lower in TPOAb-positive than negative women (38.9 vs. 48.0% and 10.1 vs. 11.3%; P = 0.04 and 0.34). After adjustment for covariates including serum thyroid stimulation hormone concentration and thyroid medication usage in multinomial regression models, TgAb-positive older women had lower odds of prefrailty and frailty compared with TgAb-negative women (odds ratio 0.57 and 0.30; 95% confidence interval 0.34–0.98 and 0.10–0.85, respectively). Similarly, TPOAb-positive older women had lower odds of frailty compared with TPOAb-negative women (odds ratio 0.44; 95% confidence interval 0.20–0.96). These trends were not observed with antinuclear antibodies. Conclusion: Independent of thyroid function status, community-dwelling older women who are seropositive for TgAbs and TPOAbs are less likely to be frail than seronegative women.